Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

NCT01789281 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Everolimus
DRUG: Sandostatin LAR Depot

Sponsor

Novartis Pharmaceuticals